"Designing Growth Strategies is in our DNA"

Specialty Generics Market Size, Share & Industry Analysis, By Route of Administration (Injectable, Oral, and Others), By Indication (Oncology, Cardiovascular, Autoimmune Diseases, Infectious Diseases, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI107533

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Major Chronic Diseases, By Key Countries, 2024/ 2025
    2. Regulatory Framework for Specialty Generics
    3. New Product Launches, By Key Players
    4. Key Industry Developments (Mergers, Acquisitions, Collaborations, etc.)
    5. Impact of COVID-19 on the Market
  5. Global Specialty Generics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable
      2. Oral
      3. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiovascular
      3. Autoimmune Diseases
      4. Infectious Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Specialty Generics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable
      2. Oral
      3. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiovascular
      3. Autoimmune Diseases
      4. Infectious Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Specialty Generics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable
      2. Oral
      3. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiovascular
      3. Autoimmune Diseases
      4. Infectious Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Specialty Generics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable
      2. Oral
      3. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiovascular
      3. Autoimmune Diseases
      4. Infectious Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. China
      2. India
      3. Japan
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Specialty Generics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable
      2. Oral
      3. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiovascular
      3. Autoimmune Diseases
      4. Infectious Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. Teva Pharmaceuticals USA, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Hikma Pharmaceuticals PLC
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Mallinckrodt
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Amneal Pharmaceuticals LLC
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Viatris Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Sun Pharmaceutical Industries, Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Endo Pharmaceuticals Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Lupin
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Dr. Reddy’s Laboratories, Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. Novartis AG
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Major Chronic Diseases, By Key Countries, 2024/ 2025
    2. Regulatory Framework for Specialty Generics
    3. New Product Launches, By Key Players
    4. Key Industry Developments (Mergers, Acquisitions, Collaborations, etc.)
    5. Impact of COVID-19 on the Market
  5. Global Specialty Generics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable
      2. Oral
      3. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiovascular
      3. Autoimmune Diseases
      4. Infectious Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Specialty Generics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable
      2. Oral
      3. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiovascular
      3. Autoimmune Diseases
      4. Infectious Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Specialty Generics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable
      2. Oral
      3. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiovascular
      3. Autoimmune Diseases
      4. Infectious Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Specialty Generics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable
      2. Oral
      3. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiovascular
      3. Autoimmune Diseases
      4. Infectious Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. China
      2. India
      3. Japan
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Specialty Generics Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable
      2. Oral
      3. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Cardiovascular
      3. Autoimmune Diseases
      4. Infectious Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. Teva Pharmaceuticals USA, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Hikma Pharmaceuticals PLC
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Mallinckrodt
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Amneal Pharmaceuticals LLC
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Viatris Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Sun Pharmaceutical Industries, Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Endo Pharmaceuticals Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Lupin
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Dr. Reddy’s Laboratories, Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. Novartis AG
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: Global Specialty Generics Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034

Figure 2: Global Specialty Generics Market Value Share (%), by Route of Administration, 2025 & 2034

Figure 3: Global Specialty Generics Market Value Share (%), by Indication, 2025 & 2034

Figure 4: Global Specialty Generics Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 5: Global Specialty Generics Market Value (USD Billion), by Region, 2025 & 2034

Figure 6: North America Specialty Generics Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 7: North America Specialty Generics Market Value Share (%), by Route of Administration, 2025

Figure 8: North America Specialty Generics Market Value (USD Billion), by Indication, 2025 & 2034

Figure 9: North America Specialty Generics Market Value Share (%), by Indication, 2025

Figure 10: North America Specialty Generics Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 11: North America Specialty Generics Market Value Share (%), by Distribution Channel, 2025

Figure 12: North America Specialty Generics Market Value (USD Billion), By Country, 2025 & 2034

Figure 13: North America Specialty Generics Market Value Share (%), By Country, 2025

Figure 14: Europe Specialty Generics Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 15: Europe Specialty Generics Market Value Share (%), by Route of Administration, 2025

Figure 16: Europe Specialty Generics Market Value (USD Billion), by Indication, 2025 & 2034

Figure 17: Europe Specialty Generics Market Value Share (%), by Indication, 2025

Figure 18: Europe Specialty Generics Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 19: Europe Specialty Generics Market Value Share (%), by Distribution Channel, 2025

Figure 20: Europe Specialty Generics Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 21: Asia Pacific Specialty Generics Market Value Share (%), by Indication, 2025

Figure 22: Asia Pacific Specialty Generics Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 23: Asia Pacific Specialty Generics Market Value Share (%), by Distribution Channel, 2025

Figure 24: Asia Pacific Specialty Generics Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 25: Asia Pacific Specialty Generics Market Value Share (%), By Country/ Sub-region, 2025

Figure 26: Rest of the World Specialty Generics Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 27: Rest of the World Specialty Generics Market Value Share (%), by Route of Administration, 2025

Figure 28: Rest of the World Specialty Generics Market Value (USD Billion), by Indication, 2025 & 2034

Figure 29: Rest of the World Specialty Generics Market Value Share (%), by Indication, 2025

Figure 30: Rest of the World Specialty Generics Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 31: Rest of the World Specialty Generics Market Value Share (%), by Distribution Channel, 2025

Figure 32: Rest of the World Specialty Generics Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 33: Rest of the World Specialty Generics Market Value Share (%), By Country/ Sub-region, 2025

Figure 34: Global Specialty Generics Market Share (%), By Company, 2025

Table 1: Global Specialty Generics Market Revenue (USD Billion) Forecast, By Route of Administration, 2021–2034

Table 2: Global Specialty Generics Market Revenue (USD Billion) Forecast, By Indication, 2021–2034

Table 3: Global Specialty Generics Market Revenue (USD Billion) Forecast, By Distribution Channel, 2021–2034

Table 4: Global Specialty Generics Market Revenue (USD Billion) Forecast, By Region, 2021–2034

Table 5: North America Specialty Generics Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 6: North America Specialty Generics Market Revenue (USD Billion) Forecast, by Indication, 2021-2034

Table 7: North America Specialty Generics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 8: North America Specialty Generics Market Revenue (USD Billion) Forecast, By Country, 2021-2034

Table 9: Europe Specialty Generics Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 10: Europe Specialty Generics Market Revenue (USD Billion) Forecast, by Indication, 2021-2034

Table 11: Europe Specialty Generics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 12: Europe Specialty Generics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 13: Asia Pacific Specialty Generics Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 14: Asia Pacific Specialty Generics Market Revenue (USD Billion) Forecast, by Indication, 2021-2034

Table 15: Asia Pacific Specialty Generics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 16: Asia Pacific Specialty Generics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 17: Rest of the World Specialty Generics Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 18: Rest of the World Specialty Generics Market Revenue (USD Billion) Forecast, by Indication, 2021-2034

Table 19: Rest of the World Specialty Generics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 20: Rest of the World Specialty Generics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Specialty Generics Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 151
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports